Tandem mass spectrometry program implementation challenges for state newborn screening programs: National survey of barriers and issues

Pediatrics

Volumn 117, Issue 5, 2006, Pages

  Feuchtbaum, Lisa ^a   Faulkner, Lisa ^b   Verghese, Shinu ^b  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Newborn screening; Program implementation; Tandem mass spectrometry

Indexed keywords

COST BENEFIT ANALYSIS; DIAGNOSTIC APPROACH ROUTE; FOLLOW UP; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH STATUS; HEALTH SURVEY; HUMAN; MATERIALS; NEWBORN DISEASE; NEWBORN SCREENING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TANDEM MASS SPECTROMETRY; ARTICLE; GOVERNMENT; INFORMATION PROCESSING; MASS SPECTROMETRY; METHODOLOGY; NEWBORN; UNITED STATES; UTILIZATION REVIEW;

DATA COLLECTION; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; NEONATAL SCREENING; STATE GOVERNMENT; UNITED STATES;

EID: 33744784315     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2633D     Document Type: Review

References (21)

1. US Government Accountability Office. Newborn Screening: Characteristics of State Programs. Washington, DC: US Government Accountability Office; 2003. Report GAO-03-449
2. Rinaldo P, Tortorelli S, Matern D. Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr Opin Pediatr. 2004;16:427-433
3. Comeau AM, Larson C, Eaton, R. Integration of new genetic diseases into statewide newborn screening: New England experience. Am J Med Genet. 2004;125C:35-41
4. Schindehette S, Atlas D, Podesta JS, Stambler L, Duffy T. A simple test could have saved Ben's life. People. August 2, 2004;107-108
5. Wheelwright J. Testing your future. Discover. July 2003;24:35-41
6. Testing your baby [transcript]. "Today Show". NBC Television. June 29 to July 2, 2004
7. Waldholz M. Testing fate: a drop of blood saves one baby: another falls ill. Wall Street Journal. June 17, 2004:A1
8. Waldholz M. Parents prod states to boost newborn testing. Wall Street Journal. July 30, 2004:B1
9. March of Dimes. Statement on Newborn Screening. White Plains, NY: March of Dimes; 2004
10. Save Babies Through Screening Foundation. Available at: www.savebabies.org/familystories.php. Accessed October 1, 2004
11. Watson M. Newborn screening: toward a uniform screening panel and system. Presented at the Second Meeting of the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; September 22-23, 2004; Washington, DC
12. Therrell BL Jr. US newborn screening policy dilemmas for the twenty-first century. Mol Genet Metab. 2001;74:64-74
13. Holtzman NA. Expanding newborn screening: how good is the evidence? JAMA. 2003;290:2606-2608
14. Dhanda RK, Reilly PR. Legal and ethical issues of newborn screening. Pediatr Ann. 2003;32:540-546
15. Mulvihill JJ, Blackett PR, Palmer SE. Expanding metabolic screening of newborns: can the health care industry do better than public health? J Okla State Med Assoc. 2003;96:477-481
16. American College of Obstetricians and Gynecologists. ACOG Committee Opinion 287, October 2003: newborn screening. Obstet Gynecol. 2003;102:887-889
17. Carreiro-Lewandowski E. Newborn screening: an overview. Clin Lab Sci. 2002;15:229-238
18. Loeber G, Webster D, Aznarez A. Quality evaluation of newborn screening programs. Acta Paediatr Suppl. 1999;88:3-6
19. Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJ, Koh HK. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep. 2001;116:122-131
20. Liebl B, Nennstiel-Ratzel U, Roscher A, von Kries R. Data required for the evaluation of newborn screening programmes. Eur J Pediatr. 2003;162(suppl 1):S57-S61
21. Dezateux C. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome. Eur J Pediatr. 2003;162(suppl 1):S25-S28